ClinConnect ClinConnect Logo
Search / Trial NCT06275776

HIP-STITCH (Wound Recovery After THA)

Launched by REINIER HAGA ORTHOPEDISCH CENTRUM · Feb 16, 2024

Trial Information

Current as of August 02, 2025

Recruiting

Keywords

Aberrant Wound Recovery Total Hip Arthroplasty Anterior Approach Monocryl Smooth Suture Vicryl Rapide Braided Suture Indermil Topical Skin Adhesive Dermabond Prineo Skin Closure System Stryker Zip Skin Closure System

ClinConnect Summary

The HIP-STITCH trial is studying how different stitching techniques affect wound healing after hip replacement surgery. Researchers will compare four types of sutures—Monocryl, Vicryl Rapide with Indermil skin glue, Dermabond Prineo, and Stryker Zip—to see which one leads to the best recovery of the surgical wound within the first two weeks after the operation. Participants will take photos of their bandage at home three days and eleven days after surgery, and a research team member will take photos of the wound during follow-up visits at seven and fourteen days.

To be eligible for this trial, participants must be at least 18 years old and scheduled for total hip arthroplasty (hip replacement) surgery at the RHOC in Zoetermeer. They should not have had any previous surgeries on the same hip and must be able to communicate in Dutch to give informed consent. Participants can expect to be part of an important study that aims to improve recovery outcomes for future patients undergoing hip replacement surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Eighteen years or older.
  • Scheduled to undergo Total Hip Arthroplasty via the anterior approach for any indication at the RHOC.
  • No prior operations to the hip which is to be operated on.
  • A good command of the Dutch language
  • Able to give written informed consent.
  • Exclusion Criteria:
  • Usage of cytostatics in the period ranging from fourteen days prior, to ninety days after the operation.
  • Unable to, or difficulty with communicating in the Dutch language (e.g. due to mental disability, inability to understand/speak/write Dutch, et cetera).

About Reinier Haga Orthopedisch Centrum

Reinier Haga Orthopedisch Centrum is a leading orthopedic center dedicated to advancing musculoskeletal care through innovative clinical trials and research. Committed to improving patient outcomes, the center specializes in a wide range of orthopedic conditions and employs a multidisciplinary approach to treatment. With a focus on evidence-based practices, the Reinier Haga Orthopedisch Centrum collaborates with healthcare professionals and researchers to develop and evaluate new therapies, ultimately enhancing the quality of care provided to patients.

Locations

Zoetermeer, Zuid Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Stephan BW Vehmeijer, Dr.

Principal Investigator

Reinier Haga Orthopedisch Centrum

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported